TrialJournal of Crohn's & colitis2025

Efficacy and safety of upadacitinib maintenance therapy in patients with moderately to severely active Crohn's disease: 2-year results from the U-ENDURE Long-Term Extension study.

Edward V Loftus et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.